1.
MENEZES AD, FRAIJI NA. Use of tyrosine kinase inhibitor by patients with chronic myeloid leukemia at a public hematology institution in the state of Amazonas, Brazil. J Hosp Pharm Health Serv [Internet]. 2020 Nov. 15 [cited 2025 Nov. 3];11(4):510. Available from: https://jhphs.org/sbrafh/article/view/510